These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15082237)

  • 1. Aberrant crypt foci and beta-catenin accumulated crypts; significance and roles for colorectal carcinogenesis.
    Mori H; Yamada Y; Kuno T; Hirose Y
    Mutat Res; 2004 May; 566(3):191-208. PubMed ID: 15082237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance and role of early-lesions in experimental colorectal carcinogenesis.
    Mori H; Hata K; Yamada Y; Kuno T; Hara A
    Chem Biol Interact; 2005 Jun; 155(1-2):1-9. PubMed ID: 15904905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of large bowel carcinogenesis; the role of control of cell proliferation and significance of beta-catenin-accumulated crypts as a new biomarker.
    Mori H; Yamada Y; Hirose Y; Kuno T; Katayama M; Sakata K; Yoshida K; Sugie S; Hara A; Yoshimi N
    Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S71-5. PubMed ID: 12570338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
    Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-cancerous lesions for colorectal cancers in rodents: a new concept.
    Yamada Y; Mori H
    Carcinogenesis; 2003 Jun; 24(6):1015-9. PubMed ID: 12807742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis.
    Yamada Y; Yoshimi N; Hirose Y; Matsunaga K; Katayama M; Sakata K; Shimizu M; Kuno T; Mori H
    Cancer Res; 2001 Mar; 61(5):1874-8. PubMed ID: 11280741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correspondence re: Y. Yamada et al., frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res., 60: 3323-3327, 2000; and sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res., 61: 1874-1878, 2001.
    Pretlow TP; Bird RP
    Cancer Res; 2001 Oct; 61(20):7699-701. PubMed ID: 11606415
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-catenin expression is altered in human colonic aberrant crypt foci.
    Hao XP; Pretlow TG; Rao JS; Pretlow TP
    Cancer Res; 2001 Nov; 61(22):8085-8. PubMed ID: 11719432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aberrant crypt foci as biomarkers in chemoprevention for colorectal cancer].
    Katsuki S; Oui M; Takayama T; Takahashi Y; Shuichi N; Niitsu Y
    Nihon Geka Gakkai Zasshi; 1998 Jun; 99(6):379-84. PubMed ID: 9695076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization of beta-catenin and APC proteins in colorectal preneoplastic and neoplastic lesions.
    Sena P; Saviano M; Monni S; Losi L; Roncucci L; Marzona L; De Pol A
    Cancer Lett; 2006 Sep; 241(2):203-12. PubMed ID: 16298038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azoxymethane-induced beta-catenin-accumulated crypts in colonic mucosa of rodents as an intermediate biomarker for colon carcinogenesis.
    Hirose Y; Kuno T; Yamada Y; Sakata K; Katayama M; Yoshida K; Qiao Z; Hata K; Yoshimi N; Mori H
    Carcinogenesis; 2003 Jan; 24(1):107-11. PubMed ID: 12538355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the malignant potential of aberrant crypt foci by immunohistochemical staining for beta-catenin in inflammation-induced rat colon carcinogenesis.
    Furihata T; Kawamata H; Kubota K; Fujimori T
    Int J Mol Med; 2002 Apr; 9(4):353-8. PubMed ID: 11891526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of chemoprevention of dietary Agaricus blazei against rat colonic aberrant crypt foci.
    Ziliotto L; Barbisan LF; Rodrigues MA
    Hum Exp Toxicol; 2008 Jun; 27(6):505-11. PubMed ID: 18784204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant crypt foci.
    Alrawi SJ; Schiff M; Carroll RE; Dayton M; Gibbs JF; Kulavlat M; Tan D; Berman K; Stoler DL; Anderson GR
    Anticancer Res; 2006; 26(1A):107-19. PubMed ID: 16475686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The modifying effect of Peucedanum japonicum, a herb in the Ryukyu Islands, on azoxymethane-induced colon preneoplastic lesions in male F344 rats.
    Morioka T; Suzui M; Nabandith V; Inamine M; Aniya Y; Nakayama T; Ichiba T; Mori H; Yoshimi N
    Cancer Lett; 2004 Mar; 205(2):133-41. PubMed ID: 15036645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant crypt foci in colon cancer epidemiology.
    Khare S; Chaudhary K; Bissonnette M; Carroll R
    Methods Mol Biol; 2009; 472():373-86. PubMed ID: 19107443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia.
    Hurlstone DP; Karajeh M; Sanders DS; Drew SK; Cross SS
    Am J Gastroenterol; 2005 Jun; 100(6):1283-9. PubMed ID: 15929758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of carcinogenesis in colorectal cancer: Precancerous lesions].
    Mori H; Yamada Y; Hirose Y
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():67-71. PubMed ID: 14574857
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppression of occurrence and advancement of beta-catenin-accumulated crypts, possible premalignant lesions of colon cancer, by selective cyclooxygenase-2 inhibitor, celecoxib.
    Yamada Y; Yoshimi N; Hirose Y; Hara A; Shimizu M; Kuno T; Katayama M; Qiao Z; Mori H
    Jpn J Cancer Res; 2001 Jun; 92(6):617-23. PubMed ID: 11429049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of adenomatous aberrant crypt foci (ACF) from hyperplastic ACF with concomitant increase in cell proliferation.
    Otori K; Sugiyama K; Hasebe T; Fukushima S; Esumi H
    Cancer Res; 1995 Nov; 55(21):4743-6. PubMed ID: 7585496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.